MedTrace Logo

Study of MK0663 in Patients With Chronic Low Back Pain (0663-806)(COMPLETED)

NCT00090181 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 401

Last updated 2022-02-15

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of MK0663 for the treatment of chronic low back pain and to investigate the overall safety and tolerability over four weeks of treatment.

Conditions

  • Chronic Low Back Pain

Interventions

DRUG

MK0663, etoricoxib / Duration of Treatment: 4 weeks

DRUG

Comparator: diclofenac / Duration of Treatment: 4 weeks

Sponsors & Collaborators

  • Organon and Co

    lead INDUSTRY

Principal Investigators

  • Medical Monitor · Merck Sharp & Dohme LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-06-30
Primary Completion
2005-03-31
Completion
2005-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00090181 on ClinicalTrials.gov